Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

CGP-37849

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
CGP-37849
Clinical data
Other namesCGP-37849, CGP-40116
Identifiers
  • (E,2R)-2-amino-4-methyl-5-phosphonopent-3-enoic acid
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC6H12NO5P
Molar mass209.138 g·mol−1
3D model (JSmol)
  • C/C(=C\[C@H](C(=O)O)N)/CP(=O)(O)O
  • InChI=1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+/t5-/m1/s1 ☒N
  • Key:BDYHNCZIGYIOGJ-XWCPEMDWSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

CGP-37849 is a competitiveantagonist at theNMDA receptor.[1] It is a potent, orally activeanticonvulsant in animal models,[2] and was researched for the treatment ofepilepsy.[3] It also hasneuroprotective activity[4] and showsantidepressant[5][6] andanxiolytic effects.[7][8]

References

[edit]
  1. ^Fagg GE, Olpe HR, Pozza MF, Baud J, Steinmann M, Schmutz M, et al. (April 1990)."CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity".British Journal of Pharmacology.99 (4):791–7.doi:10.1111/j.1476-5381.1990.tb13008.x.PMC 1917531.PMID 1972895.
  2. ^Schmutz M, Portet C, Jeker A, Klebs K, Vassout A, Allgeier H, et al. (July 1990). "The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents".Naunyn-Schmiedeberg's Archives of Pharmacology.342 (1):61–6.doi:10.1007/bf00178973.PMID 1976233.S2CID 25531153.
  3. ^Fujikawa DG, Daniels AH, Kim JS (March 1994). "The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage".Epilepsy Research.17 (3):207–19.doi:10.1016/0920-1211(94)90051-5.PMID 7912191.S2CID 13656613.
  4. ^Gutnikov SA, Gaffan D (June 1996)."Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys".The Journal of Neuroscience.16 (12):4041–5.doi:10.1523/JNEUROSCI.16-12-04041.1996.PMC 6578604.PMID 8656297.
  5. ^Maj J, Klimek V, Gołembiowska K, Rogóz Z, Skuza G (1993). "Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity".Polish Journal of Pharmacology.45 (5–6):455–66.PMID 7912134.
  6. ^Papp M, Moryl E (September 1994). "Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression".European Journal of Pharmacology.263 (1–2):1–7.doi:10.1016/0014-2999(94)90516-9.PMID 7821340.
  7. ^Jessa M, Nazar M, Bidzinski A, Plaznik A (March 1996). "The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety".European Neuropsychopharmacology.6 (1):55–61.doi:10.1016/0924-977x(95)00068-z.PMID 8866939.S2CID 45953054.
  8. ^Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E (July 2000). "The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats".Neuropharmacology.39 (10):1858–64.doi:10.1016/s0028-3908(00)00023-x.PMID 10884566.S2CID 33660694.
AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
KARTooltip Kainate receptor
NMDARTooltip N-Methyl-D-aspartate receptor
Retrieved from "https://en.wikipedia.org/w/index.php?title=CGP-37849&oldid=1175813960"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp